| Code | 9534D | ||||||||||
| MA number | 58/0023/22-S | ||||||||||
| Product Form: | tbl 60x5 mg/1,25 mg (blis.OPA/Al/PVC//Al) | ||||||||||
| MA Status: | R - Valid Marketing Authorisation | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| MAH, country: | KRKA, d.d., Novo mesto, Slovenia | ||||||||||
| Therapeutic Class: | 58 - HYPOTENSIVA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 24 | ||||||||||
| Container: | blister OPA/Al/PVC/Al | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 04.02.2022 |
| Validity: | 04.02.2027 |
| Pediatric warnings: | Yes |
| PIL: |
PIL_Co-Prenessa Neo_04/2023.pdf
|
| SPC: |
SPC_Co-Prenessa Neo 5mg/1,25mg_04/2023.pdf
|
| Safety feature | Yes |
| Data update: | 04.02.2022 |
